These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5035304)

  • 21. The postnatal development of noradrenaline uptake in the adrenergic nerves of different tissues from the rat.
    Sachs C; de Champlain J; Malmfors T; Olson L
    Eur J Pharmacol; 1970 Jan; 9(1):67-79. PubMed ID: 5434295
    [No Abstract]   [Full Text] [Related]  

  • 22. [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].
    Constantinidis J; Bartholini G; Geissbühler F; Tissot R
    Experientia; 1970 Apr; 26(4):381-3. PubMed ID: 5439606
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
    Modigh K
    Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

  • 25. Mode of action of L-DOPA on central noradrenaline mechanisms.
    Andén NE; Engel J; Rubenson A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):1-10. PubMed ID: 4260802
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
    Malmors T; Abrams WB
    J Pharmacol Exp Ther; 1970 Jul; 174(1):99-110. PubMed ID: 4316536
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 29. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine.
    de Champlain J
    Can J Physiol Pharmacol; 1971 Apr; 49(4):345-55. PubMed ID: 5124933
    [No Abstract]   [Full Text] [Related]  

  • 30. Some observations on the site of action of oxypertin.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson J; Malmfors T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(4):450-63. PubMed ID: 5622482
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 33. Uptake and accumulation of erythro-and threo-methyl-noradrenaline in adrenergic nerves.
    Jonsson G; Sachs C
    Eur J Pharmacol; 1971 Oct; 16(2):180-91. PubMed ID: 5161257
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 35. Noradrenaline uptake into cerebral cortex: a histochemical study.
    Arbuthnott GW
    J Neurochem; 1969 Dec; 16(12):1599-604. PubMed ID: 4908291
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine.
    Jonsson G; Pycock C; Fuxe K; Sachs C
    J Neurochem; 1974 Mar; 22(3):419-26. PubMed ID: 4829965
    [No Abstract]   [Full Text] [Related]  

  • 37. Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Hamberger B; Malmfors T; Sachs C
    Eur J Pharmacol; 1969 Oct; 8(1):58-72. PubMed ID: 5357075
    [No Abstract]   [Full Text] [Related]  

  • 38. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
    Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
    [No Abstract]   [Full Text] [Related]  

  • 39. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
    Landsberg L
    Biochem Pharmacol; 1971 Dec; 20(12):3542-7. PubMed ID: 5132898
    [No Abstract]   [Full Text] [Related]  

  • 40. Active uptake of tritiated metaraminol by mouse brain slices in vitro.
    Ross SB; Renyi AL
    Life Sci; 1966 Apr; 5(7):639-47. PubMed ID: 4381260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.